Serina Therapeutics (SER) Total Debt (2017 - 2025)
Serina Therapeutics (SER) posted Total Debt of $2.9 million for Q3 2025, down 74.11% sequentially from $11.2 million in Q3 2024, and down 74.11% YoY from $11.2 million in Q3 2024.
Serina Therapeutics (SER) Total Debt (2017 - 2025) Analysis & Trends
Serina Therapeutics has reported Total Debt for 9 years, with the latest figure at $2.9 million in Q3 2025.
- Quarterly Total Debt fell 74.11% year-over-year to $2.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.9 million (down 74.11% YoY) and the FY2022 annual result came in at $18.1 million, up 37.28% from the prior year.
- Total Debt fell to $2.9 million in Q3 2025 per SER's latest filing, from $11.2 million in the prior quarter.
- Over five years, Total Debt peaked at $33.0 million in Q2 2023 and troughed at $2.2 million in Q3 2023.
- A 5-year average of $12.9 million and a median of $11.1 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2025: Total Debt soared 402.7% in 2024, then sank 74.11% in 2025.
- Over 5 years, Total Debt stood at $13.2 million in 2021, then jumped by 37.28% to $18.1 million in 2022, then tumbled by 87.76% to $2.2 million in 2023, then jumped by 402.7% to $11.2 million in 2024, then tumbled by 74.11% to $2.9 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $2.9 million, $11.2 million, and $11.1 million for Q3 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.89 Mn |
| Sep 30, 2024 | 11.16 Mn |
| Jun 30, 2024 | 11.14 Mn |
| Mar 31, 2024 | 10.44 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 33.01 Mn |
| Mar 31, 2023 | 30.05 Mn |
| Dec 31, 2022 | 18.12 Mn |
| Sep 30, 2022 | 8.41 Mn |
| Jun 30, 2022 | 13.72 Mn |
| Mar 31, 2022 | 10.87 Mn |
| Dec 31, 2021 | 13.20 Mn |
| Sep 30, 2021 | 11.41 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Mar 31, 2021 | 7.35 Mn |
| Dec 31, 2020 | 5.86 Mn |
| Sep 30, 2020 | 3.53 Mn |
| Jun 30, 2020 | 3.55 Mn |
| Mar 31, 2020 | 1.77 Mn |
| Dec 31, 2019 | 1.59 Mn |